Related Articles
Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy
Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer
Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives (Review)
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer